About alectinib
ALK inhibitor anticancer medicine
Used for
- Treats ALK-positive non-small cell lung cancer in adults.
- May be used after surgery or for advanced cancer, depending on treatment plan.
Usual adult dose
600 mg by mouth twice daily with food; dose adjustments may be needed.
Common side effects
- Constipation, tiredness, or muscle pain
- Swelling or rash
- Liver test abnormalities
- Slow heartbeat or anemia
Important warnings
- Can cause serious liver problems; blood tests are needed.
- May cause muscle injury, kidney problems, or a slow heartbeat.
- Can cause severe lung inflammation; seek urgent assessment for new breathing problems.
- Avoid pregnancy during treatment and for at least three months afterward; men should use contraception during treatment and for three months afterward.
Pregnancy
May harm an unborn baby. Effective contraception is recommended during treatment and for at least three months after the last dose.
Breastfeeding
Do not breastfeed during treatment and for one week after the last dose.
Interactions
- Strong CYP3A inhibitors or inducers may affect alectinib levels.
- Grapefruit may affect medicine levels; discuss use with a healthcare professional.
- Alectinib may interact with medicines processed by CYP3A enzymes.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.